Seven hospitals under WVU Medicine recently collaborated with Magnolia Medical, the creators of the Steripath blood culture collection device, for a product review and feedback session. This gathering took place at the United Hospital Center in Bridgeport, West Virginia, where representatives from various hospitals within the system met with developers from Seattle. The session aimed to provide clinical insights and gather feedback on the challenges faced in blood culture collection. Participants had the opportunity to test a new generation of the device and offer design feedback. The adoption of Steripath technology by WVU Medicine has significantly reduced blood culture contamination, resulting in an annual cost avoidance of $3.5 million. This initiative supports efforts in antimicrobial stewardship and cost reduction in healthcare. Dr. Mark Povroznik, Vice President of Quality and Safety at UHC, emphasized the importance of this collaboration, noting that advancements in technology are simplifying the blood culture collection process. This partnership highlights the positive impact of collaborative efforts on product development and underscores WVU Medicine’s leadership in reducing contamination rates.
How is WVU Medicine collaborating with Magnolia Medical to advance medical device technology?
